CY1123596T1 - Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης - Google Patents
Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινηςInfo
- Publication number
- CY1123596T1 CY1123596T1 CY20201100985T CY201100985T CY1123596T1 CY 1123596 T1 CY1123596 T1 CY 1123596T1 CY 20201100985 T CY20201100985 T CY 20201100985T CY 201100985 T CY201100985 T CY 201100985T CY 1123596 T1 CY1123596 T1 CY 1123596T1
- Authority
- CY
- Cyprus
- Prior art keywords
- coccidiosis
- treatment
- compositions
- intramuscular
- triazine compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σε συνθέσεις και μεθόδους για θεραπεία της κοκκιδίωσης σε μη-ανθρώπινα θηλαστικά. Πιο ιδιαιτέρως, η εφεύρεση αφορά σε ενδομυϊκές συνθέσεις και μεθόδους για θεραπεία κοκκιδίωσης με τριαζίνη.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12306547.6A EP2740470A1 (en) | 2012-12-07 | 2012-12-07 | Treatment of Coccidiosis with intramuscular triazine composition |
EP13815401.8A EP2928455B1 (en) | 2012-12-07 | 2013-12-06 | Treatment of coccidiosis with intramuscular triazine compositions |
PCT/EP2013/075757 WO2014086959A1 (en) | 2012-12-07 | 2013-12-06 | Treatment of coccidiosis with intramuscular triazine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123596T1 true CY1123596T1 (el) | 2022-03-24 |
Family
ID=47351541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100985T CY1123596T1 (el) | 2012-12-07 | 2020-10-19 | Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης |
Country Status (22)
Country | Link |
---|---|
US (1) | US20150320756A1 (el) |
EP (4) | EP2740470A1 (el) |
JP (1) | JP2016501253A (el) |
KR (1) | KR102242354B1 (el) |
CN (3) | CN112426426A (el) |
AU (1) | AU2013353983A1 (el) |
BR (1) | BR112015013178A2 (el) |
CA (2) | CA3177623A1 (el) |
CL (1) | CL2015001564A1 (el) |
CY (1) | CY1123596T1 (el) |
DK (2) | DK2928455T3 (el) |
ES (2) | ES2816525T3 (el) |
HR (1) | HRP20201703T1 (el) |
HU (1) | HUE051190T2 (el) |
MX (2) | MX2015007129A (el) |
PH (1) | PH12015501283A1 (el) |
PL (2) | PL3566695T3 (el) |
PT (1) | PT3566695T (el) |
RU (2) | RU2717821C2 (el) |
SI (1) | SI3566695T1 (el) |
UA (1) | UA115344C2 (el) |
WO (1) | WO2014086959A1 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007025908A1 (de) | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
EP2740469A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | New treatments with triazines |
EP2740470A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | Treatment of Coccidiosis with intramuscular triazine composition |
EP2740492A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | Triazine formulations with a second active ingredient and surfactant(s) |
EP3578182A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulations containing triazinones and iron with a low amount of free iron ions |
EP3578181A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies |
KR102259950B1 (ko) * | 2021-02-17 | 2021-06-02 | 경상국립대학교산학협력단 | 복합 이온미네랄 용액을 유효성분으로 함유하는 콕시듐증의 예방 또는 개선용 조성물 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1183940A (en) | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
US3970752A (en) * | 1973-03-20 | 1976-07-20 | Bayer Aktiengesellschaft | Coccidiocidal compositions utilizing 1-phenyl-substituted 1,3,5-triazine |
DE2718799A1 (de) | 1977-04-27 | 1978-11-09 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer |
US4493826A (en) * | 1982-01-25 | 1985-01-15 | Schering Corporation | Gentamicin-gleptoferron compositions |
US5219853A (en) | 1983-01-12 | 1993-06-15 | Bayer Aktiengesellschaft | Agent for coccidiosis |
DE3300793A1 (de) | 1983-01-12 | 1984-07-12 | Bayer Ag, 5090 Leverkusen | Coccidiosemittel |
DE3516632A1 (de) | 1985-05-09 | 1986-11-13 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 1,3,5-triazintrionen |
JPH0776524A (ja) * | 1993-07-13 | 1995-03-20 | Takeda Chem Ind Ltd | 動物用抗貧血剤 |
DE19603954C2 (de) | 1996-02-05 | 2003-04-17 | Wagon Automotive Gmbh | Prallträger für ein Kraftfahrzeug |
DE19603984A1 (de) | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
US6470017B1 (en) | 1998-04-21 | 2002-10-22 | Nippon Telegraph And Telephone Corporation | Packet multiplexing apparatus |
DE19824483A1 (de) | 1998-06-02 | 1999-12-09 | Bayer Ag | Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon |
CN1189175C (zh) * | 1998-10-08 | 2005-02-16 | 高新研究公司 | 用于预防和治疗原虫病的组合物和方法 |
AU4034800A (en) | 1999-10-08 | 2001-04-23 | New Ace Research Company | Novel compositions and methods for prevention and treatment of protozoal disease |
DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
DE102004042958A1 (de) * | 2004-09-02 | 2006-03-09 | Bayer Healthcare Ag | Neue antiparasitäre Kombination von Wirkstoffen |
WO2006058426A1 (en) | 2004-12-01 | 2006-06-08 | Wlt Distributors Inc. | Needle-free injector |
ES2785210T3 (es) | 2006-06-07 | 2020-10-06 | Acushot Inc | Mecanismo de carga para un inyector sin aguja |
DE102006038292A1 (de) | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen |
DE102007025908A1 (de) * | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
CN102112167A (zh) | 2008-03-07 | 2011-06-29 | 医用注射器公司 | 皮内注射器及其用途 |
SI22751A (sl) | 2008-04-03 | 2009-10-31 | Krka, D.D., Novo Mesto | Toltrazuril z izboljĺ animi lastnostmi za raztapljanje |
US20100257667A1 (en) | 2009-04-10 | 2010-10-14 | James Kennedy | Ventilated Toilet |
FR2946882B1 (fr) * | 2009-06-18 | 2011-08-26 | Ceva Sante Animale | Suspension veterinaire gelifiee de fer |
DE102009038949A1 (de) * | 2009-08-26 | 2011-03-03 | Bayer Animal Health Gmbh | Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen |
CN101947201B (zh) | 2010-09-08 | 2011-12-28 | 洛阳惠中兽药有限公司 | 兽药纳米混悬剂及其制备方法与应用 |
CN102512366A (zh) | 2011-12-28 | 2012-06-27 | 广州市和生堂动物药业有限公司 | 妥曲珠利悬浮乳剂及其制备方法 |
CN102743334A (zh) * | 2012-07-30 | 2012-10-24 | 郑州后羿制药有限公司 | 一种妥曲珠利注射剂及其制备方法 |
EP2740470A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | Treatment of Coccidiosis with intramuscular triazine composition |
EP2740469A1 (en) * | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | New treatments with triazines |
EP3578181A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies |
-
2012
- 2012-12-07 EP EP12306547.6A patent/EP2740470A1/en not_active Withdrawn
-
2013
- 2013-12-06 EP EP13815401.8A patent/EP2928455B1/en active Active
- 2013-12-06 BR BR112015013178A patent/BR112015013178A2/pt not_active Application Discontinuation
- 2013-12-06 RU RU2015127023A patent/RU2717821C2/ru active
- 2013-12-06 WO PCT/EP2013/075757 patent/WO2014086959A1/en active Application Filing
- 2013-12-06 HU HUE19180399A patent/HUE051190T2/hu unknown
- 2013-12-06 SI SI201331807T patent/SI3566695T1/sl unknown
- 2013-12-06 CA CA3177623A patent/CA3177623A1/en active Pending
- 2013-12-06 DK DK13815401T patent/DK2928455T3/da active
- 2013-12-06 CA CA2892887A patent/CA2892887C/en active Active
- 2013-12-06 CN CN202011426731.4A patent/CN112426426A/zh active Pending
- 2013-12-06 AU AU2013353983A patent/AU2013353983A1/en not_active Abandoned
- 2013-12-06 JP JP2015546023A patent/JP2016501253A/ja not_active Withdrawn
- 2013-12-06 PL PL19180399T patent/PL3566695T3/pl unknown
- 2013-12-06 CN CN201380064038.9A patent/CN104994840A/zh active Pending
- 2013-12-06 MX MX2015007129A patent/MX2015007129A/es unknown
- 2013-12-06 DK DK19180399.8T patent/DK3566695T3/da active
- 2013-12-06 EP EP19180399.8A patent/EP3566695B1/en active Active
- 2013-12-06 ES ES19180399T patent/ES2816525T3/es active Active
- 2013-12-06 KR KR1020157018138A patent/KR102242354B1/ko active IP Right Grant
- 2013-12-06 PT PT191803998T patent/PT3566695T/pt unknown
- 2013-12-06 US US14/650,052 patent/US20150320756A1/en not_active Abandoned
- 2013-12-06 ES ES13815401T patent/ES2761574T3/es active Active
- 2013-12-06 EP EP20187714.9A patent/EP3747429A1/en active Pending
- 2013-12-06 CN CN202010468261.1A patent/CN111714450A/zh active Pending
- 2013-12-06 PL PL13815401T patent/PL2928455T3/pl unknown
- 2013-12-06 UA UAA201506702A patent/UA115344C2/uk unknown
-
2015
- 2015-06-05 CL CL2015001564A patent/CL2015001564A1/es unknown
- 2015-06-05 MX MX2021006166A patent/MX2021006166A/es unknown
- 2015-06-05 PH PH12015501283A patent/PH12015501283A1/en unknown
-
2020
- 2020-03-18 RU RU2020111176A patent/RU2020111176A/ru unknown
- 2020-10-19 CY CY20201100985T patent/CY1123596T1/el unknown
- 2020-10-22 HR HRP20201703TT patent/HRP20201703T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123596T1 (el) | Θεραπεια της κοκκιδιωσης με ενδομυϊκες συνθεσεις τριαζινης | |
CY1120556T1 (el) | Δικυκλικα ετεροκυκλα ως αναστολεις fgfr | |
CY1122478T1 (el) | Συνθεσεις που περιεχουν anti-cd38 αντισωματα και λεναλιδομιδη | |
CY1122159T1 (el) | Συνθεσεις irna του γονιδιου serpina1 και μεθοδοι χρησης τους | |
CY1120035T1 (el) | Πυριμιδοπυριμιδινονες χρησιμες ως αναστολεις της wee-1 κινασης | |
EA201891910A1 (ru) | Гетероарильные ингибиторы pad4 | |
CY1123490T1 (el) | Συνθεσεις που προερχονται απο χιτοζανη | |
CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
EA201591137A1 (ru) | Ингибиторы mk2 и их применения | |
TR201811764T4 (tr) | Kinaz inhibitörleri olarak aminoheteroaril benzamidleri. | |
EA201592225A1 (ru) | КОМПОЗИЦИИ НА ОСНОВЕ iRNA TMPRSS6 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
MX2015012401A (es) | Composiciones y metodos de alterar niveles de colesterol. | |
EA201891251A1 (ru) | Бициклические ингибиторы pad4 | |
CY1117654T1 (el) | Πολυαιθυλενογλυκολιωμενη απελινη και χρησεις αυτης | |
EA201891347A1 (ru) | Аза-бензимидазольные ингибиторы pad4 | |
CY1120597T1 (el) | Νεα χρηση | |
EA201591705A1 (ru) | Композиции и способы для диагностики и лечения рака печени | |
CY1122998T1 (el) | Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη | |
EA201690557A1 (ru) | Способы лечения синдрома ломкой х-хромосомы и связанных расстройств | |
CY1124378T1 (el) | Ενωσεις για αγωγη του αποκλεισμου επαναμυελινωσης σε παθησεις που συσχετιζονται με την εκφραση της πρωτεϊνης φακελου herv-w | |
EA201590503A1 (ru) | Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями | |
CY1120276T1 (el) | Απομονωμενη στερεη μορφη μονοϋδροχλωρικη αναμορελινης με χαμηλη γραμμομοριακη αναλογια χλωριου:αναμορελινης και χαμηλη περιεκτικοτητασε καταλοιπα οργανικου διαλυτη | |
EA201591709A1 (ru) | 5-бром-индирубины | |
CY1119470T1 (el) | Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη | |
BR112016012248A2 (pt) | método de tratamento de nefropatia |